European Union - English - EMA (European Medicines Agency)

immedica pharma ab - glycerol phenylbutyrate - urea cycle disorders, inborn - other alimentary tract and metabolism products, - ravicti is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate-synthase-i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

Israel - English - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of adult and paediatric patients ≥2 months of age with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate-synthase-i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

Israel - English - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of adult and paediatric patients ≥2 months of age with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate-synthase-i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

Israel - English - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of adult and paediatric patients ≥2 months of age with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate-synthase-i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone. ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

Israel - English - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate synthetase i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

Israel - English - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate synthetase i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

Israel - English - Ministry of Health

medison pharma ltd - glycerol phenylbutyrate - liquid - glycerol phenylbutyrate 1.1 g / 1 ml - glycerol phenylbutyrate - ravicti is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate synthetase i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).

Canada - English - Health Canada

horizon therapeutics ireland dac - glycerol phenylbutyrate - liquid - 1.1g - glycerol phenylbutyrate 1.1g - various alimentary tract and metabolism products